News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


Aspirin a viable treatment for serious blood clots

5 November, 2012

Aspirin a viable treatment for serious blood clots, study shows

Low-dose aspirin is a cheap and effective way to prevent potentially deadly blood clots in the leg or the lungs in patients who have had a previous blood clot a new study shows.

The study, conducted by the National Health and Medical Research Council’s Clinical Trials Centre at the University of Sydney, and a team of international investigators, is published today in The New England Journal of Medicine.

The study has found that people who have suffered blood clots in the veins of the leg (deep vein thrombosis or DVT) or the lungs (pulmonary embolism or PE) are less likely to suffer a recurrence of the serious blood clots or a cardiac event if they take low-dose aspirin. These conditions affect approximately 1 in 1000 people in Australia each year.

“The results of this study suggest the simple, inexpensive treatment of low-dose aspirin could prevent thousands of patients from experiencing recurrent clots each year and may make substantial healthcare savings in Australia and worldwide,” Professor John Simes, Director of the NHMRC Clinical Trials Centre at the University of Sydney and chair of the study said.

“These results suggest that aspirin prevents about one third of recurrent blood clot events. For every 1000 patients treated for one year, aspirin can be expected to prevent about 20 to 30 episodes of recurrent major thrombotic events at the cost of about 3 significant bleeding episodes.”

Operating since 2003, the ASPIRE study completed recruitment of 822 participants from five countries including Australia, New Zealand, Singapore, India and Argentina. All the participants had previously suffered a DVT or PE that occurred for no particular reason, called ‘unprovoked VTE’ (venous thromboembolism).

They had completed on average six months of anti-coagulant treatment, generally with warfarin. They were randomly allocated to receive either low dose enteric coated aspirin or a matching placebo. On average participants were followed for three years.

Dr Tim Brighton, from Prince of Wales Hospital and principal investigator of the study, explained:

“Many patients discontinue warfarin therapy after six or twelve months of treatment due to the inconvenience of regular blood tests and the increased risks of serious bleeding [putting them at high risk of recurring thrombosis].”

“Aspirin reduces the risk of important blood clotting event including recurrent VTE, myocardial infarction, stroke, or cardiovascular death. We now have clear evidence that aspirin is of benefit for patients who are unable or do not wish to continue warfarin in the long term.”

The study results are consistent with the findings of an Italian study, called WARFASA, which a showed a significant benefit with aspirin as reported in the The New England Journal of Medicine earlier this year.

When combined, the results of the two trials show clear and consistent evidence that aspirin prevents recurrent blood clots and this is likely to be adopted into future international practice.

© Scoop Media

Culture Headlines | Health Headlines | Education Headlines


Scoop Review Of Books: Before The Quakes

Remembering Christchurch: Voices from decades past: The Christchurch I lived in for my first 23 years was where four-year-olds walked alone to kindergarten, crossing roads empty of all but a couple of cars per hour. My primary school, Ilam, was newly built on a grassy paddock surrounded by rural land... More>>

6-11 October: New Zealand Improvisation Festival Hits Wellington

Wellingtonians will have a wide selection of improv to feast on with a jam packed programme containing 22 shows, three companies from Australia, two companies from Auckland, one from Nelson, one from Christchurch and seven from Wellington. More>>


Bird Of The Year: New Zealanders Asked To Vote For Their Favourite Native Bird

Te Radar, David Farrier, Heather du-Plessis Allan and Duncan Garner are just some of the New Zealanders championing their favourite native bird in Forest & Bird’s annual Bird of the Year competition, which kicks off today.. More>>


Werewolf Film: It Follows - Panic In Detroit

Philip Matthews: When you heard last month that Wes Craven had died and you wanted to pay homage, you could have sat down with any one of five of his films that helped reinvent American horror at least three times over three decades... Or you could just have watched one of the greatest recent horror films that would probably not exist without Craven. More>>


Werewolf Music: Searching For The White Wail - On Art Pepper, etc

If the word ‘hipster’ means anything – which it arguably doesn’t – it seems to be more of an impulse than a condition. One always headed for the margins, and away from the white-bred, white-bread mainstream... More>>


Scoop Review Of Books: Leonardo da Vinci - The Graphic Work

The breadth of da Vinci’s work is incredible: from animals to weaponry, architecture to fabric, maps to botany. The works have been divided into themes such as Proportion Drawings, Anatomical Drawings and Drawings of Maps and Plans. Each section begins with a short essay. More>>

Scoop Review Of Books: James Hector: Explorer, Scientist, Leader

Publication of this comprehensive 274-page account of the life and work of James Hector by the Geoscience Society of New Zealand marks the 150th anniversary of James Hector’s appointment as New Zealand’s first government scientist. More>>

Get More From Scoop



Search Scoop  
Powered by Vodafone
NZ independent news